Tien Liang Biotech Co

Tien Liang Biotech Co Current Liabilities

Current Liabilities of Tien Liang Biotech Co (4127.TWO) as of Nov 19, 2026.

Current Liabilities

-TWD

Last updated:

Current Liabilities of Tien Liang Biotech Co is 2026 - TWD. Current Liabilities of Tien Liang Biotech Co was 2025 - TWD. It decreases by % lower compared to the previous year.

The Tien Liang Biotech Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2011
523.09 M TWD
Jan 1, 2012
460.43 M TWD
Jan 1, 2013
312.83 M TWD
Jan 1, 2014
326.89 M TWD
Jan 1, 2015
469.50 M TWD
Jan 1, 2016
367.43 M TWD
Jan 1, 2017
275.72 M TWD
Jan 1, 2018
210.62 M TWD
The Tien Liang Biotech Co Current Liabilities history
YEARCurrent LiabilitiesYoY
210.62 MTWD-23.61%
275.72 MTWD-24.96%
367.43 MTWD-21.74%
469.50 MTWD+43.62%
326.89 MTWD+4.50%
312.83 MTWD-32.06%
460.43 MTWD-11.98%
523.09 MTWD+12.33%
465.68 MTWD+12.20%
415.04 MTWD-16.95%
499.73 MTWD-7.93%
542.80 MTWD-5.74%
575.85 MTWD+7.63%
535.03 MTWD+2.06%
524.25 MTWD+10.97%
472.43 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tien Liang Biotech Co Stock analysis

What does Tien Liang Biotech Co do? Tien Liang BioTech Co. Ltd. manufactures and sells Chinese herbal and western medicine, including active pharmaceutical ingredients (APIs), biopharmaceuticals, and traditional Chinese medicines. The company imports, wholesales, and retails western medicines domestically. Its products are distributed within the domestic market, targeting healthcare providers and consumers seeking traditional and modern pharmaceutical solutions. The firm's revenue streams come from the sale of manufactured medicines, APIs, biopharmaceuticals, and retail distribution of western medicines. Domestic market sales form the core of its business, with no mention of international distribution channels. The company serves both the traditional Chinese medicine segment and the modern pharmaceutical segment through its comprehensive product portfolio. Tien Liang BioTech operates within the pharmaceutical manufacturing and distribution sector, focusing on domestic sales of herbal, western, and biopharmaceutical products. Its business model integrates manufacturing, import, wholesale, and retail operations to serve the local healthcare market. Tien Liang Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tien Liang Biotech Co stock

On Eulerpool you can find the complete historical development of Current Liabilities Tien Liang Biotech Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Tien Liang Biotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Tien Liang Biotech Co

All Key Metrics — Tien Liang Biotech Co